Chemical Compound Review:
Triacetate (3Z)-4,6,6-trihydroxyhexa- 3,5-dien-2-one
Synonyms:
Paleo,
Aurrecoechea,
Jung,
Rapoport,
Richardson,
Lindley,
Bartlett,
Will,
Bouman,
van Olden,
Stoutenbeek,
Taylor,
Liu,
- Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate. Fujiwara, M., Ijichi, K., Tokuhisa, K., Katsuura, K., Shigeta, S., Konno, K., Wang, G.Y., Uemura, D., Yokota, T., Baba, M. Antimicrob. Agents Chemother. (1996)
- Synthesis and antitumor activity of fluorine-substituted 4-amino-2(1H)-pyridinones and their nucleosides. 3-Deazacytosines. McNamara, D.J., Cook, P.D. J. Med. Chem. (1987)
- Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Lonnemann, G., Behme, T.C., Lenzner, B., Floege, J., Schulze, M., Colton, C.K., Koch, K.M., Shaldon, S. Kidney Int. (1992)
- Mutagenic effects of 4-hydroxynonenal triacetate, a chemically protected form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y/Tk+/- mouse lymphoma cells. Singh, S.P., Chen, T., Chen, L., Mei, N., McLain, E., Samokyszyn, V., Thaden, J.J., Moore, M.M., Zimniak, P. J. Pharmacol. Exp. Ther. (2005)
- In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Evans, R.C., Holmes, C.J. Blood Purif. (1991)
- Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics. Welage, L.S., Mason, N.A., Hoffman, E.J., Odeh, R.M., Dombrouski, J., Patel, J.A., Swartz, R.D. J. Am. Soc. Nephrol. (1995)
- Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients. Rao, M., Guo, D., Jaber, B.L., Sundaram, S., Cendoroglo, M., King, A.J., Pereira, B.J., Balakrishnan, V.S. Kidney Int. (2004)
- Di- and triester prodrugs of the varicella-zoster antiviral agent 6-methoxypurine arabinoside. Jones, L.A., Moorman, A.R., Chamberlain, S.D., de Miranda, P., Reynolds, D.J., Burns, C.L., Krenitsky, T.A. J. Med. Chem. (1992)
- Use of 'solid-state' promoters in the electrochemistry of cytochrome c at a gold electrode. Santucci, R., Faraoni, A., Campanella, L., Tranchida, G., Brunori, M. Biochem. J. (1991)
- Dermal absorption and metabolism of the antipsoriatic drug dithranol triacetate. Wiegrebe, W., Retzow, A., Plumier, E., Ersoy, N., Garbe, A., Faro, H.P., Kunert, R. Arzneimittel-Forschung. (1984)
- The treatment of psoriasis with azaribine. Deneau, D.G., Farber, E.M. Dermatologica (1975)
- Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. Kammerau, B., Zesch, A., Schaefer, H. J. Invest. Dermatol. (1975)
- Asymmetric syntheses of (-)-8-epi-swainsonine triacetate and (+)-1, 2-Di-epi-swainsonine. Carbonyl addition thwarted by an unprecedented aza-pinacol rearrangement. Razavi, H., Polt, R. J. Org. Chem. (2000)
- Formal enantiospecific synthesis of (+)-FR900482. Paleo, M.R., Aurrecoechea, N., Jung, K.Y., Rapoport, H. J. Org. Chem. (2003)
- Production and characterization of a monoclonal antibody cross-reactive with most group A trichothecenes. Fan, T.S., Schubring, S.L., Wei, R.D., Chu, F.S. Appl. Environ. Microbiol. (1988)
- A new route to 7-substituted derivatives of n-[4-(2-[2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimidin-5-yl]ethyl)benzoyl]-L-glutamic acid [ALIMTA (LY231514, MTA)]. Taylor, E.C., Liu, B. J. Org. Chem. (2001)
- Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances. Smee, D.F., Sidwell, R.W., Clark, S.M., Barnett, B.B., Spendlove, R.S. Antimicrob. Agents Chemother. (1981)
- Characteristics of the cellulose triacetate membrane for hemofiltration. Sato, H., Kidaka, T. The International journal of artificial organs. (1983)
- Behaviour of mouse macrophage cell line and mouse fibroblast on copolymers containing cellulose triacetate. Shigemasa, Y., Sashiwa, H., Tanioka, S., Saimito, H., Tanigawa, T., Tanaka, Y. Int. J. Biol. Macromol. (1992)
- The use of filtration techniques for the lysis and study of red blood cells. Hultquist, D.E., Vasko, M.R., Gray, R.H. Am. J. Hematol. (1977)
- Cohort mortality study of prostate cancer among chemical workers. Whorton, M.D., Amsel, J., Mandel, J. Am. J. Ind. Med. (1998)
- Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus. Gilbert, B.E., Wyde, P.R., Wilson, S.Z., Robins, R.K. Antimicrob. Agents Chemother. (1991)
- Effect of surface-attached heparin on the response of potassium-selective electrodes. Brooks, K.A., Allen, J.R., Feldhoff, P.W., Bachas, L.G. Anal. Chem. (1996)
- Phenylalanine ammonia-lyase entrapped in fibers. Marconi, W., Bartoli, F., Gianna, R., Morisi, F., Spotorno, G. Biochimie (1980)
- Cellular proliferation and second messenger formation altered by dialysis membranes. Pacini, S., Aterini, S., Salvadori, M., Ippolito, E., Ruggiero, M., Amato, M. Nephrol. Dial. Transplant. (1997)
- Salicylic acid determination in cow urine and drugs using a bienzymatic sensor. Campanella, L., Gregori, E., Tomassetti, M. Journal of pharmaceutical and biomedical analysis. (2006)
- Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Bouman, C.S., van Olden, R.W., Stoutenbeek, C.P. Blood Purif. (1998)
- The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. Lonnemann, G., Schindler, R., Lufft, V., Mahiout, A., Shaldon, S., Koch, K.M. Nephrol. Dial. Transplant. (1995)
- A randomized, controlled study of the consequences of hemodialysis membrane composition on erythropoietic response. Richardson, D., Lindley, E.J., Bartlett, C., Will, E.J. Am. J. Kidney Dis. (2003)
- Membrane-entrapped microperoxidase as a 'solid-state' promoter in the electrochemistry of soluble metalloproteins. Brunori, M., Santucci, R., Campanella, L., Tranchida, G. Biochem. J. (1989)
- Vitamin B6 and hemodialysis: the impact of high-flux/high-efficiency dialysis and review of the literature. Kasama, R., Koch, T., Canals-Navas, C., Pitone, J.M. Am. J. Kidney Dis. (1996)
- Efficiency of three different hemodialysis membranes for plasma porphyrin removal. Fontanellas, A., Herrero, J.A., Moran, M.J., Coronel, F., Sepulveda, P., Barrientos, A., Enriquez De Salamanca, R. Am. J. Kidney Dis. (1995)
- Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study. de Pont, A.C., Oudemans-van Straaten, H.M., Roozendaal, K.J., Zandstra, D.F. Crit. Care Med. (2000)
- Radioimmunoassay of nivalenol in barley. Teshima, R., Hirai, K., Sato, M., Ikebuchi, H., Ichinoe, M., Terao, T. Appl. Environ. Microbiol. (1990)
- High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. Floege, J., Granolleras, C., Deschodt, G., Heck, M., Baudin, G., Branger, B., Tournier, O., Reinhard, B., Eisenbach, G.M., Smeby, L.C. Nephrol. Dial. Transplant. (1989)
- Immobilization of alpha-amylase into photographic gelatin by chemical cross-linking. Bayramoglu, Z., Akbulut, U., Sungur, S. Biomaterials (1992)